Apellis Pharmaceuticals (APLS) reported an unexpected delay for its eye-disease treatment, leading APLS stock to crash and taking shares of Iveric Bio (ISEE) with it. X Late Thursday, Apellis said it ...
Apellis Pharmaceuticals (APLS) reported an unexpected delay for its eye-disease treatment, leading APLS stock to crash and taking shares of Iveric Bio (ISEE) with it. X Late Thursday, Apellis said it ...